BioCardia logo
BioCardia
BCDA | NASDAQ
Chart Builder DCF Calculator
$0.79
-$0.04 (-4.93%)
At close: Nov 16, 2026, 4:00 PM ET
$0.81
+$0.02 (+3.16%)
After-hours: Nov 16, 2026, 7:43 PM ET

BioCardia Company Profile

Company profile explained

Company Profile

BioCardia, Inc. is a pioneering clinical-stage company dedicated to regenerative medicine, focusing on the development of advanced cellular and cell-derived therapies for a range of cardiac and respiratory ailments. Central to its pipeline is the CardiAMP Cell Therapy System, designed to address heart failure and chronic myocardial ischemia. Additionally, BioCardia is advancing an allogeneic cell therapy program, also targeting cardiac and pulmonary conditions. The company is further exploring a specific allogeneic cell therapeutic platform. This investigational treatment, derived from culture-expanded mesenchymal cells sourced from bone marrow, is currently undergoing Phase I/II trials for patients suffering from ischemic systolic heart failure. Beyond its therapeutic candidates, BioCardia also provides innovative delivery solutions. These include the Helix biotherapeutic delivery system, engineered to precisely administer treatments directly into the heart muscle via an internal penetrating helical needle, and a line of Morph deflectable guides and sheaths. BioCardia maintains its headquarters in Sunnyvale, California.

Key Executives

Name Position
Peter A. Altman Chief Executive Officer, President & Director
David McClung Chief Financial Officer
Edward Gillis Senior Vice President of Devices
Miranda Peto Benvenuti Investor Relations Executive

Latest SEC Filings

Date Type Title
Oct 20, 2026 4 Filing
Oct 19, 2026 8-K Current Report
Oct 07, 2026 8-K Current Report
Oct 01, 2026 8-K Current Report
Sep 30, 2026 4 Filing
Sep 23, 2026 4 Filing
Sep 23, 2026 8-K Current Report
Sep 21, 2026 8-K Current Report
Sep 10, 2026 8-K Current Report
Sep 04, 2026 4 Filing
View All SEC Filings ➞
BioCardia
BioCardia logo
Country United States
IPO Date Nov 13, 1996
Industry Biotechnology
Sector Healthcare
Employees 17
CEO Peter A. Altman

Contact Details

320 Soquel Way Sunnyvale, California 94085 United States

Stock Details

Ticker Symbol BCDA
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000925741
CUSIP Number 09060U606
ISIN Number US09060U6064
SIC Code 2836

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.